Stroke remains the leading cause of death in China, killing more than 2 million people each year, despite a decade of advances by the world’s most populous country in combating the disease. China made significant strides decreasing mortality rates from strokes a... Read More
The incidence of stroke is on the rise in Taiwan, driven by unhealthy eating habits, the prevalence of cigarette smoking and high alcohol consumption. A new study presented at the ASEAN Federation of Cardiology Congress in September found the disease that affects... Read More
Driven by economic growth and expanding access to healthcare, the in-vitro diagnostics (IVD) market is rapidly expanding across the Asia-Pacific region. With an aging population, the region is experiencing significant rise in chronic conditions that can be diagnosed and monitored using IVD... Read More
According to Galen Growth Asia, Asian healthcare funding rose significantly in the third quarter of 2018. There were 78 deals done in the third quarter for about $1.4 billion. They expect healthcare funding deals to total about $6 billion in 2018. There... Read More
With obesity on the rise among Japan’s aging population, so is diabetes. More than ten million Japanese were estimated to be living with the disease as of 2016, according to a survey released by the country’s Ministry of Health, Labor and Welfare... Read More
Seventeen years after it first became the leading cause of death in Japan, cancer remains the number one killer in the archipelago nation, according to a study commissioned by the country’s Ministry of Health, Labor and Welfare. Ever since 1947, when the... Read More
This article was originally published on Medtech Intelligence. This article is a continuation of the two-part series on the hospital sector in Asia. Last month’s article focused on China’s hospital growth. This month’s article will expand on the status and prospects of... Read More
Under popular pressure to boost the affordability of cancer medications, China’s health insurance regulator announced in August that it will add a range of cancer drugs to the list of those already covered by the national medical insurance system. At the same... Read More
This article was originally published on Medtech Intelligence. Hospitals in key Asian countries are enjoying strong growth prospects, spurred by aging populations, a rising middle class, an expansion of public health insurance, and the encouragement of private and foreign investment in the... Read More
The market in India for in vitro diagnostics (IVDs)—the simple but effective laboratory tests on tissue samples used to detect diseases, conditions, and infections—is growing by a rapid 8.6% annually, according to a report from The Business Research Company. India’s IVD market... Read More